chartexchange

CLNN
Clene Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:57:27 PM EDT
4.10USD+1.990%(+0.08)61,483
Loading…
Loading…
Healthcare
Biotechnology
HQ
Salt Lake City, UT, USA
Previous Close
$4.02
Beta
1.92
52-Week High
$13.50 2025-11-03
52-Week Low
$3.25 2026-09-15
SMA 50
$4.38
SMA 200
$5.41
Avg. Vol 10D
88,059
Avg. Vol 30D
122,467
Avg. Vol 90D
96,727
Relative Vol
0.50
9.59M
2.5900%
360
Nov 12, 2026 (38d)
Jul 11, 2024 · 1-for-20 (reverse)
CLNN Profile

clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. our patented clean-surface nanosuspension™ (csn) technology produces clean-surface nanocrystals at commercially viable rates. by coupling high-purity metallic donor materials with high-purity water, csn unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.

CLNN Performance
PeriodPriceDateChangeBeta
1W4.062026-09-28+1.72%1.182
1M3.852026-09-04+7.27%2.365
3M6.012026-07-06-31.28%1.752
6M5.762026-04-06-28.30%1.182
1Y10.512025-10-03-60.70%1.922
2Y5.302024-10-04-22.07%—
5Y150.602021-10-04-97.26%0.836
CLNN Stock Summary

Clene Inc. Common Stock (NASDAQ:CLNN) stock price today is $4.13, and today's volume is 61,483. CLNN is up 2.736% today. The 30 day average volume is 122,467. CLNN market cap is $58.70M with 14.21M shares outstanding.